Baird Financial Group’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.65M Buy
154,893
+43,629
+39% +$2.21M 0.01% 675
2026
Q1
$5.94M Buy
111,264
+10,232
+10% +$601K 0.01% 692
2025
Q4
$6.28M Sell
101,032
-2,668
-3% -$165K 0.01% 670
2025
Q3
$6.23M Sell
103,700
-52
-0.1% -$3.18K 0.01% 672
2025
Q2
$6.5M Buy
103,752
+126
+0.1% +$7.57K 0.01% 634
2025
Q1
$6.24M Buy
103,626
+2,838
+3% +$176K 0.01% 611
2024
Q4
$5.88M Sell
100,788
-1,342
-1% -$79.8K 0.01% 637
2024
Q3
$6.05M Buy
102,130
+1,096
+1% +$62.6K 0.01% 621
2024
Q2
$5.66M Sell
101,034
-5,377
-5% -$301K 0.01% 628
2024
Q1
$6.23M Sell
106,411
-322
-0.3% -$18.2K 0.01% 607
2023
Q4
$5.76M Sell
106,733
-1,031
-1% -$50.4K 0.01% 623
2023
Q3
$5.23M Sell
107,764
-6,023
-5% -$320K 0.01% 618
2023
Q2
$6.42M Buy
113,787
+7,050
+7% +$388K 0.02% 552
2023
Q1
$5.76M Sell
106,737
-4,453
-4% -$237K 0.01% 549
2022
Q4
$5.84M Sell
111,190
-2,672
-2% -$136K 0.02% 541
2022
Q3
$5.37M Sell
113,862
-7,294
-6% -$378K 0.02% 547
2022
Q2
$6.11M Sell
121,156
-1,560
-1% -$85K 0.02% 542
2022
Q1
$7.48M Sell
122,716
-643
-0.5% -$38.3K 0.02% 514
2021
Q4
$8.12M Sell
123,359
-979
-0.8% -$62.7K 0.02% 489
2021
Q3
$7.81M Sell
124,338
-14,322
-10% -$914K 0.02% 480
2021
Q2
$8.34M Sell
138,660
-420
-0.3% -$24.3K 0.02% 465
2021
Q1
$7.66M Sell
139,080
-3,018
-2% -$167K 0.02% 464
2020
Q4
$7.75M Buy
142,098
+31,086
+28% +$1.62M 0.02% 433
2020
Q3
$5.54M Buy
111,012
+10,776
+11% +$522K 0.02% 471
2020
Q2
$4.42M Buy
100,236
+15,870
+19% +$678K 0.02% 506
2020
Q1
$3.17M Buy
84,366
+4,500
+6% +$189K 0.01% 550
2019
Q4
$3.52M Buy
79,866
+7,332
+10% +$308K 0.01% 612
2019
Q3
$2.99M Buy
72,534
+21,216
+41% +$869K 0.01% 657
2019
Q2
$2.06M Buy
+51,318
New +$1.94M 0.01% 772
2019
Q1
Sell
-49,494
Closed -$1.65M 1302
2018
Q4
$1.65M Sell
49,494
-1,728
-3% -$59.8K 0.01% 683
2018
Q3
$1.94M Buy
+51,222
New +$1.82M 0.01% 675

Other funds holding IHI

Baird Financial Group's IHI Position: Q2 2026 in Review

Baird Financial Group increased its iShares US Medical Devices ETF (IHI) stake by 39% in Q2 2026, buying an estimated $2.21M and bringing the position to 154,893 shares worth $7.65M. The position accounts for 0.01% of the portfolio, ranked #675.

Baird Financial Group first reported a position in IHI in Q3 2018 and has held it in 31 quarters since. The position peaked at $8.34M in Q2 2021. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Baird Financial Group held 154,893 shares of iShares US Medical Devices ETF worth $7.65M as of Q2 2026.
  • Baird Financial Group bought 43,629 iShares US Medical Devices ETF shares in Q2 2026, an estimated $2.21M.
  • iShares US Medical Devices ETF made up 0.01% of Baird Financial Group's portfolio in Q2 2026, its #675 holding.
  • Baird Financial Group first reported a position in iShares US Medical Devices ETF in Q3 2018 and has held it in 31 quarters since.
  • Baird Financial Group's iShares US Medical Devices ETF position peaked at $8.34M in Q2 2021.
  • 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.